BPG is committed to discovery and dissemination of knowledge
Open-Access Journal
Review
Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis 
Gianni Testino, Paolo Borro 
World J Hepatol 5(10):521-527. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.521
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations 
Rosa Zampino, Aldo Marrone, Luciano Restivo, Barbara Guerrera, Ausilia Sellitto, Luca Rinaldi, Ciro Romano, Luigi E Adinolfi 
World J Hepatol 5(10):528-540. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.528
Cytoprotective role of heme oxygenase-1 and heme degradation derived end products in liver injury 
Clarice Silvia Taemi Origassa, Niels Olsen Saraiva Câmara 
World J Hepatol 5(10):541-549. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.541
Minireviews
Lipotoxicity in the liver 
Veronika Zámbó, Laura Simon-Szabó, Péter Szelényi, Éva Kereszturi, Gábor Bánhegyi, Miklós Csala 
World J Hepatol 5(10):550-557. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.550
Original Article
Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH 
Stephan Laggai, Yvette Simon, Theo Ranssweiler, Alexandra K Kiemer, Sonja M Kessler 
World J Hepatol 5(10):558-567. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.558
Brief Article
Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis 
Ourania Sfakianaki, Maria Tzardi, Argyro Voumvouraki, Aikaterini Afgoustaki, Meri Koulentaki, Elias Kouroumalis 
World J Hepatol 5(10):568-576. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.568
Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome 
Eirini I Rigopoulou, Kalliopi Zachou, Nikolaos K Gatselis, Georgia Papadamou, George K Koukoulis, George N Dalekos 
World J Hepatol 5(10):577-583. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.577
Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco 
Mohamed Tahiri, Mustapha Sodqi, Fatima Ez Zahra Lahdami, Latifa Marih, Hassan Lamdini, Wafaa Hliwa, Ahd Oulad Lahcen, Wafaa Badre, Fouad Haddad, Abdelfetah Chakib, Ahmed Bellabah, Rhimou Alaoui, Kamal Marhoum El Filali 
World J Hepatol 5(10):584-588. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.584
Case Report
A fascinating presentation of hepatic hydrothorax 
Vinaya Gaduputi, Hassan Tariq, Kalyan Kanneganti 
World J Hepatol 5(10):589-591. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.589
Severe cholestasis due to adalimumab in a Crohn’s disease patient 
Edward Kim, Brian Bressler, David F Schaeffer, Eric M Yoshida 
World J Hepatol 5(10):592-595. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.592
Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot “Prunus mume” 
Takashi Hoshino, Hitoshi Takagi, Atsushi Naganuma, Eri Koitabashi, Sanae Uehara, Naomi Sakamoto, Tomohiro Kudo, Ken Sato, Satoru Kakizaki 
World J Hepatol 5(10):596-600. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.596
Letters To The Editor
A correction of misinformation regarding Herbalife 
Kristy Appelhans, Raushanah Najeeullah, Vasilios Frankos 
World J Hepatol 5(10):601-602. Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.601